Dr. Lal Path Labs Operational Benchmarking
₹1,950.50-0.70%
- Market cap
- ₹32,569 crore
- P/E
- 60.1
- P/B
- 12.99
- ROE
- 21.6%
- Dividend yield
- 0.46%
Dr. Lal Path Labs compared with sector peers on revenue, market capitalization, valuation, and return metrics.
Dr. Lal Path Labs sector benchmarking & peer comparison
Operational and financial KPI comparison against sector peers.
| Company | LTP (₹) | P/E | Market Cap (₹ cr) | Div Yield | Qtr Sales (₹ cr) | ROCE % |
|---|---|---|---|---|---|---|
| Dr. Lal Path Labs Ltd. | ₹1,950.50 | 60.1 | 32,569 | 1.2% | 4,500 | 21.6% |
| Median (1 Cos) | ₹1,950.50 | 60.1 | 32,569 | 1.2% | 4,500 | 21.6% |
Source: NSE sector index filings and financial statements. Data as of 7 October 2026. How this data is compiled.
Same Data For Peers
- Vijaya Diagnostic Centre Limited operational benchmarking
- Metropolis Healthcare Limited operational benchmarking
- Thyrocare Technologies Limited operational benchmarking
- Laurus Labs Limited operational benchmarking
- Krsnaa Diagnostics Limited operational benchmarking
- Lincoln Pharmaceuticals Limited operational benchmarking
Trade Dr. Lal Path Labs With ATS
Track LALPATHLAB live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.